Knowledge of drug effects on non-target systems is essential for appropriate safety monitoring of amiodarone and digoxin.
Supports monitoring non-target effects to enhance amiodarone and digoxin safety; leaves open optimal protocols pending prospective trials.
Patients on a range of drug therapies are often not monitored appropriately, even though this can improve patient safety. Knowledge of the effects of drugs on non-target body systems is essential to guide monitoring and interpretation of monitoring tests
No takes yet. Share an insight, caveat, or question.
Smellie et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Persistent AF managementMore from BMJ